FDA, CE, TGA - all regulations cleared, page-135

We have 10 consecutive trading days staying above 6c, still requires another 10 consecutive days to stay above 6c to meet first part of the conditions.
I am sure CEO would be encouraging to do something to boost share price, in order to meet a part of vesting conditions, then working towards achieving an operating profit for second half of 2020 financial year (1 January 2020 - 30 June 2020).

I like the vesting conditions the company set up.

I think it will be a bit quiet after traders exited.
GLTA.

Possible Near term news flow:

• TALi deployment and expansion into education sector well underway
• Significant post quarter event related to reimbursement access now allows the Company to expedite discussions with significant potential partners
• Potential partner and insurer discussions progressing well with an accelerated timeline now in place
• The Company intends to provide further guidance on the deployment and billing schedule for both TALi Detect and TALi Train in the near future as it works with physicians, customers and any potential partners in the U.S. during launch over the coming quarters.



"TALi Train is currently the only regulatory cleared early childhood digital cognitive assessment and training program and with all development and compliance requirements achieved we are now set to execute on our go to market strategy to realise the potential of this world-leading technology"


------------------------------------
The 14,377,766 options are proposed to be issued in two tranches (with 7,188,883 options in each tranche).
Each option to be issued will have an exercise price of $0.03 and an expiry date of 3 October 2022.

Vesting Conditions

The 7,188,883 tranche 1 options are subject to the following vesting conditions:

(a) the Shares trading on the ASX at a minimum of $0.06 per Share for any consecutive 20 trading days during the period from 3 October 2019 and until 3 October 2022, and

(b) the Company achieving an operating profit for 2HFY20 (in the case that there are changes to the business plan approved by the Board, the Board will determine in good faith any revision to the operating profit vesting criteria).

The 7,188,883 tranche 2 options are subject to the following vesting conditions:

(a) the Shares trading on the ASX at a minimum of $0.09 per Share for any consecutive 20 trading days during the period from 3 October 2020 and until 3 October 2022, and

(b) the Company achieving an operating profit for 2HFY20 (in the case that there are changes to the business plan approved by the Board, the Board will determine in good faith any revision to the operating profit vesting criteria).